Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/28/1998CA2272341A1 Antisense oligonucleotide compositions for selectively killing cancer cells
05/28/1998CA2272280A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998CA2272249A1 Treatment of neurodegenerative conditions with nimesulide
05/28/1998CA2272065A1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271941A1 Triaryl substituted imidazoles and methods of use
05/28/1998CA2271893A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998CA2271814A1 New phosphonates, process for preparing the same and medicaments
05/28/1998CA2271786A1 Multivalent salts of pyridostigmine and related compounds
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2271273A1 Methods of prevention and treatment of ischemic damage
05/28/1998CA2270478A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application
05/28/1998CA2270407A1 Human kdel receptor
05/28/1998CA2269941A1 New manufacturing process of metoprolol
05/28/1998CA2269910A1 New process for the preparation of morphinans
05/28/1998CA2269759A1 Ethylenediaminetriacetic acid and n-acyl ethylenediamenetriacetic acid silver chelactants
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998CA2267782A1 Raf kinase inhibitors
05/28/1998CA2267634A1 Methods and compounds for inhibiting .beta.-amyloid peptide release and/or synthesis
05/28/1998CA2267158A1 Detergent cosmetic compositions and use thereof
05/28/1998CA2267065A1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositionscomprising same, and methods for inhibiting beta-amyloid peptide release a nd/or its synthesis by use of such compounds
05/27/1998EP0844245A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them
05/27/1998EP0844244A1 Drug resistance and multidrug resistance modulators
05/27/1998EP0844241A1 Inhibitor for narcotic analgetic dependence/resistance acquisition
05/27/1998EP0844002A1 Use of activated hemicellulose for the induction of interleukin-12
05/27/1998EP0844000A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis
05/27/1998EP0843999A1 Use of estrogen agonists/antagonists for the manufacture of a medicament in the treatment of atherosclerosis independent of a lipid lowering effect
05/27/1998EP0843998A1 Oral pharmaceutical composition having antipyretic, analgesic and antiinflammatory activity
05/27/1998EP0843681A1 Heterocycle-fused thiazole derivatives
05/27/1998EP0843680A1 Process for the preparation of potassium clavulanate
05/27/1998EP0843679A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
05/27/1998EP0843678A1 1,9-diazabicyclo 4.3.0]nona-3,8-diene derivatives
05/27/1998EP0843677A1 4-amino-3-acylnaphthyridine derivatives
05/27/1998EP0843676A1 Ipratropium bromide enantiomer with a prolonged duration of action
05/27/1998EP0843675A1 Aza-anthracyclinone derivatives
05/27/1998EP0843674A1 Lubeluzole n-oxide
05/27/1998EP0843672A1 One pot synthesis of 2-oxazolidinone derivatives
05/27/1998EP0843671A1 Heterocyclic compounds and pharmaceutical compositions containing them
05/27/1998EP0843670A1 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof
05/27/1998EP0843663A1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
05/27/1998EP0843661A1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
05/27/1998EP0843660A1 Heterocyclic compounds, their preparation and use
05/27/1998EP0843658A1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998EP0843556A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
05/27/1998EP0843555A1 Liposomal oligonucleotide compositions
05/27/1998EP0843554A1 Ascorbyl-phosphoryl-cholesterol
05/27/1998EP0843553A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
05/27/1998EP0843552A2 Pharmaceutical formulations
05/27/1998EP0843551A1 Endothelin receptor antagonists
05/27/1998EP0843550A1 Nitric oxide synthase (nos) inhibitors
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0843548A2 Stabilized steroid compositions
05/27/1998EP0843547A1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
05/27/1998EP0786253A4 Agent for suppressing tumour growth
05/27/1998EP0720551B1 Hydraulic system for anti-lock braking installations in motor vehicles
05/27/1998EP0714387B1 New bis-naphthalimides for the treatment of cancer
05/27/1998EP0687268B1 Spiroazacyclic derivatives as substance p antagonists
05/27/1998EP0666861B1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
05/27/1998EP0664697B1 Ranitidine chewable tablets
05/27/1998EP0658082B1 Combination of germicidal agents
05/27/1998EP0656889B1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
05/27/1998EP0646125B1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
05/27/1998EP0618800B1 Glycosylated steroid derivatives for transport across biological membranes and process for making same
05/27/1998EP0596937B1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same
05/27/1998CN1183102A Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/27/1998CN1183099A Pyrido (2, 3 -d) pyrimidines for inbibiting protein tyrosine kinase mediated cellular proliferation
05/27/1998CN1183097A Radiosensitizing diamines and their pharmaceutical preparations
05/27/1998CN1183096A Optically active thiazolidinone derivatives
05/27/1998CN1183049A Oral Pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
05/27/1998CN1183048A Oral pharmaceutical dosage forms comprising a proton pump inhibitor and nsaid
05/27/1998CN1183047A Oral Pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
05/27/1998CN1183045A Substances extracted from dictyotales, Preparation method therefor, and compositions containing same
05/27/1998CN1183043A Preparation and use of sulfated oligosaccharides
05/27/1998CN1183042A Drug containing methotrexate derivative
05/27/1998CN1183041A Indazolecarboxamides
05/27/1998CN1183039A Novel collagen formulations
05/27/1998CN1182741A 3 -amidochromanylsulfonyl (thio) ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
05/27/1998CN1182739A N-benzylazolium derivatives
05/27/1998CN1182737A New 2-(1H) -quinolinone compounds, process for preparing them and pharmaceutical compositions containing them
05/27/1998CN1182734A Imidaxolyl-substituted cyclohexane derivant
05/27/1998CN1182619A External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof
05/27/1998CN1182592A Stable prostaglandin E1-containing injectable composition
05/27/1998CN1182591A Improvement for prevention of mammary gland cancer or the prevention of mammary gland canner
05/27/1998CN1182590A Method for prevention of mammary gland cancer
05/27/1998CN1182589A Medical use of 5 -hydroxymethyl -2 -furol
05/27/1998CN1182588A Usage of schube thinamine in the preparation of medicinal composition for treating mental montional and psychological intelligent diseases
05/27/1998CN1038511C Imidazopyridine and preparation process and its pharmaceutic usage
05/27/1998CN1038510C Process for the synthesis of ergoline derivatives
05/27/1998CN1038509C Process for preparing 8-chloroquinolone derivatives
05/27/1998CN1038506C Preparation process of acylaminoindole derivatives
05/27/1998CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
05/27/1998CN1038477C Oral liquor for treatment of psoriasis
05/27/1998CN1038475C Anticoccidial composition
05/27/1998CN1038474C Stable extended release oral dosage composition
05/27/1998CA2217153A1 Human methionine synthase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer
05/26/1998US5756832 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring
05/26/1998US5756818 Hydrogenation; protecting; deprotecting; clathrates
1 ... 6649 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 ... 7860